BIT 2.70% 3.8¢ biotron limited

Ann: Letter to Shareholders, page-3

  1. 632 Posts.
    lightbulb Created with Sketch. 99
    Dear Shareholders I am pleased to report that Biotron is in the final stage of three Phase 2 clinical trials for HIV‐1 and COVID‐19. This is a pivotal time for the Company as it completes data collection and analyses of samples and information collected during the trials ahead of the release of headline data in the coming weeks.

    I like the wording "Release of headline data"
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
0.001(2.70%)
Mkt cap ! $34.28M
Open High Low Value Volume
3.7¢ 4.0¢ 3.7¢ $68.85K 1.794M

Buyers (Bids)

No. Vol. Price($)
2 150000 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 349950 3
View Market Depth
Last trade - 15.10pm 28/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.